Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14437402 | 0.86 | TSHR (0.32) | — | |
| SCHEMBL4360016 | 0.85 | NAAA (0.44) | — | |
| SCHEMBL14437403 | 0.83 | ACHE (0.35) | ACHECYP4F2CYP4A11TDP1GAA | |
| SCHEMBL10225081 | 0.83 | ALDH1A1 (0.38) | ACHECYP4F2CYP4A11TDP1GAA | |
| SCHEMBL5369764 | 0.83 | ALDH1A1 (0.38) | ACHECYP4F2CYP4A11TDP1GAA | |
| SCHEMBL12135625 | 0.81 | ALDH1A1 (0.39) | ACHECYP4F2CYP4A11 | |
| SCHEMBL13714423 | 0.77 | — | — | |
| SCHEMBL6061006 | 0.76 | ACHE (0.42) | ACHECYP4F2CYP4A11GAA | |
| SCHEMBL15014430 | 0.75 | ACHE (0.37) | ACHECYP4F2CYP4A11TDP1 | |
| SCHEMBL12135643 | 0.75 | ALDH1A1 (0.40) | CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7262321-B2 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20070100096-A1 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070100096-A1 | Salt suitable for an acid generator and a chemically amplified resist composition containing the same | KCNH3, KCNN4, NHERF1 | ACHE 4857/4885CYP4F2 462/4885CYP4A11 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.